8-azidoadenosine-3',5'-monophosphate has been researched along with cyclosporine in 1 studies
Studies (8-azidoadenosine-3',5'-monophosphate) | Trials (8-azidoadenosine-3',5'-monophosphate) | Recent Studies (post-2010) (8-azidoadenosine-3',5'-monophosphate) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
---|---|---|---|---|---|
119 | 1 | 1 | 30,547 | 3,802 | 6,558 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE | 1 |
1 trial(s) available for 8-azidoadenosine-3',5'-monophosphate and cyclosporine
Article | Year |
---|---|
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agents; Azides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Dermatologic Agents; Erythrocyte Membrane; Etretinate; Female; Humans; Keratolytic Agents; Male; Middle Aged; Protein Binding; Psoriasis; Retinoids; Severity of Illness Index | 2002 |